| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.006 |